For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is 'unfair'
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. to get the shot.
‘I have no options’: Canadians criticize lack of Novavax COVID shot
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
Health Canada approves updated Novavax COVID-19 vaccine
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The protein-based vaccine, called Nuvaxovid, targets the JN.1 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant, the agency said in an online update.
Canadian government not ordering Novavax's protein-based COVID-19 vaccine this year
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing low demand.
For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is 'unfair,' advocates say
There are currently no events scheduled on LIVE3. Check back soon to watch live events from across Canada and the world!
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season.
Hosted on MSN2mon
Novavax drops as J.P. Morgan cuts to Underweight after recent rally
The deal led J.P. Morgan to upgrade the stock at the time, as the company received $500M from the French drugmaker as part of the partnership that tied up Nuvaxovid with Sanofi’s (SNY ...
Fall 2024 COVID-19 guide: The status of COVID in Canada, available vaccines — and strains expected to dominate winter
Currently, the KP.3 and KP.3.1.1 FLiRT variants, derivatives of KP.1 and KP.2, are the most prevalent in Canada and the ...